Differential inhibition of P450 isoforms by HIV protease inhibitors.

被引：0
|
作者：
Rasca, AF [1 ]
Bonnabry, P [1 ]
Leemann, T [1 ]
Dayer, P [1 ]
机构：
[1] Univ Hosp Geneva, Div Clin Pharmacol & Pharm, Geneva, Switzerland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII53
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [1] Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir
    Eagling, VA
    Back, DJ
    Barry, MG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (02) : 190 - 194
  • [2] Prevalence of scaffolds in P450 inhibitors.
    Kho, R
    Koch, K
    Hansen, MR
    Hodges, J
    Sanglimsuwan, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U208 - U208
  • [3] Prevalence of scaffolds in P450 inhibitors.
    Kho, R
    Koch, K
    Hansen, MR
    Hodges, J
    Sanglimsuwan, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U202 - U202
  • [4] Endothelium-dependent hyperpolarization and cytochrome P450 monooxygenases (P450) inhibitors.
    Corriu, C
    Feletou, M
    Canet, E
    Vanhoutte, PM
    FASEB JOURNAL, 1996, 10 (03): : 55 - 55
  • [5] Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors
    von Moltke, LL
    Greenblatt, DJ
    Granda, BW
    Giancarlo, GM
    Duan, SX
    Daily, JP
    Harmatz, JS
    Shader, RI
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (01): : 85 - 91
  • [6] Adamantyl propargyl ethers as cytochrome P450 inhibitors.
    Foroozesh, M
    Smith, TP
    Mesbah, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U323 - U323
  • [7] Synthesis of flavonids as potential cytochrome P450 inhibitors.
    Smith, TP
    Foroozesh, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U347 - U347
  • [8] Adamantyl propargyl ethers as cytochrome P450 inhibitors.
    Foroozesh, M
    Smith, TP
    Mesbah, J
    CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (12) : 1670 - 1671
  • [9] In vitro inhibition of LAAM metabolism by HIV protease inhibitors.
    Davit, B
    Cherstniakova, S
    Mojsiak, J
    Cantilena, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 154 - 154
  • [10] P450 interaction with HIV protease inhibitors: Relationship between metabolic stability, inhibitory potency, and p450 binding spectra
    Chiba, M
    Jin, LX
    Neway, W
    Vacca, JP
    Tata, JR
    Chapman, K
    Lin, JH
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (01) : 1 - 3
12345